ARTICLE | Clinical News
Access Pharmaceuticals preclinical data
February 2, 2009 8:00 AM UTC
In mouse xenograft models of breast cancer, Angiolix significantly inhibited tumor growth. Additionally, the activity of the humanized IgG1k mAb that binds to Lactadherin was enhanced when given in c...